About dfcbt-admin
This author has not written his bio yet.
But we are proud to say that dfcbt-admin contributed 15 entries already.
Entries by dfcbt-admin
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
May 31, 2016 /0 Comments/in Trainee, Trainee Publications /by dfcbt-adminOlenchock BA, Moslehi J, Baik AH, Davidson SM, Williams J, Gibson WJ, Chakraborty AA, Pierce KA, Miller CM, Hanse EA, Kelekar A, Sullivan LB, Wagers AJ, Clish CB, Vander Heiden MG, Kaelin WG Jr. (2016), EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection, Cell, 164: 884-95.
The phosphatidylinositol 3-kinase (PI3K) isoform dependence of tumor formation is determined by the genetic mode of PI3K pathway activation rather than by tissue type.
March 23, 2016 /0 Comments/in Trainee, Trainee Publications /by dfcbt-adminUtermark T, Schmit F, Lee SH, Gao X, Schaffhausen BS, Roberts TM. The phosphatidylinositol 3-kinase (PI3K) isoform dependence of tumor formation is determined by the genetic mode of PI3K pathway activation rather than by tissue type. J Virol. 2014 Sep;88(18):10673-9. PMCID: PMC4178865.
Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.
February 23, 2016 /0 Comments/in Trainee, Trainee Publications /by dfcbt-adminYang X, Coulombe-Huntington J, Kang S, Sheynkman GM, Hao T, Richardson A, Sun S, Yang F, Shen YA, Murray RR, Spirohn K, Begg BE, Duran-Frigola M, MacWilliams A, Pevzner SJ, Zhong Q, Trigg SA, Tam S, Ghamsari L, Sahni N, Yi S, Rodriguez MD, Balcha D, Tan G, Costanzo M, Andrews B, Boone C, Zhou XJ, Salehi-Ashtiani K, Charloteaux […]
Coming Soon!
January 5, 2016 /0 Comments/in Announcements /by dfcbt-adminTRIM24 is an oncogenic transcriptional activator in prostate cancer
October 21, 2015 /0 Comments/in Symposium Abstracts /by dfcbt-adminDevelopment of Selective Covalent Janus Kinase 3 Inhibitors.
August 27, 2015 /0 Comments/in Trainee, Trainee Publications /by dfcbt-adminTan L, Akahane K, McNally R, Reyskens KM, Ficarro SB, Liu S, Herter-Sprie GS, Koyama S, Pattison MJ, Labella K, Johannessen L, Akbay EA, Wong KK, Frank DA, Marto JA, Look TA, Arthur JS, Eck MJ, Gray NS. Development of Selective Covalent Janus Kinase 3 Inhibitors. J Med Chem. 2015 Aug 27;58(16):6589-606. PMCID: PMC4777322.
Correction for Hwang et al., Polyomavirus small T antigen interacts with yes-associated protein to regulate cell survival and differentiation.
July 23, 2015 /0 Comments/in Trainee, Trainee Publications /by dfcbt-adminHwang JH, Pores Fernando AT, Faure N, Andrabi S, Adelmant G, Hahn WC, Marto JA, Schaffhausen BS, Roberts TM. Correction for Hwang et al., Polyomavirus small T antigen interacts with yes-associated protein to regulate cell survival and differentiation. J Virol. 2015 Jul;89(13):6971. PMCID: PMC4468481.
Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigens.
March 23, 2015 /0 Comments/in Trainee, Trainee Publications /by dfcbt-adminWhite EA, Kramer RE, Hwang JH, Pores Fernando AT, Naetar N, Hahn WC, Roberts TM, Schaffhausen BS, Livingston DM, Howley PM. Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigens. J Virol. 2015 Mar;89(5):2857-65. PMCID: PMC4325735.
Polyomavirus small T antigen interacts with yes-associated protein to regulate cell survival and differentiation.
October 23, 2014 /0 Comments/in Trainee, Trainee Publications /by dfcbt-adminHwang JH, Pores Fernando AT, Faure N, Andrabi S, Adelmant G, Hahn WC, Marto JA, Schaffhausen BS, Roberts TM. Polyomavirus small T antigen interacts with yes-associated protein to regulate cell survival and differentiation. J Virol. 2014 Oct;88(20):12055-64. PMCID: PMC4178709